Articolo pubblicato su Rivista: [38604] Home page tipologia

Sfoglia
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 601 a 620 di 38.604
Titolo Data di pubblicazione Autore(i) File
Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer 1-gen-2013 Beyer, J; Albers, P; Altena, R; Aparicio, J; Bokemeyer, C; Busch, J; Cathomas, R; Cavallin-Stahl, E; Clarke, Nw; Claßen, J; Cohn-Cedermark, G; Dahl, Aa; Daugaard, G; De Giorgi, U; De Santis, M; De Wit, M; De Wit, R; Dieckmann, Kp; Fenner, M; Fizazi, K; Flechon, A; Fossa, Sd; Germá Lluch, Jr; Gietema, Ja; Gillessen, S; Giwercman, A; Hartmann, Jt; Heidenreich, A; Hentrich, M; Honecker, F; Horwich, A; Huddart, Ra; Kliesch, S; Kollmannsberger, C; Krege, S; Laguna, Mp; Looijenga, Lh; Lorch, A; Lotz, Jp; Mayer, F; Necchi, A; Nicolai, N; Nuver, J; Oechsle, K; Oldenburg, J; Oosterhuis, Jw; Powles, T; Rajpert-De Meyts, E; Rick, O; Rosti, G; Salvioni, R; Schrader, M; Schweyer, S; Sedlmayer, F; Sohaib, A; Souchon, R; Tandstad, T; Winter, C; Wittekind, C.
[18F]fluorodeoxyglucose positron emission tomography for outcome prediction of mammalian target of rapamycin inhibitor therapy. 1-gen-2010 De Giorgi, U; Amadori, D.
Salvage high-dose chemotherapy for children with extragonadal germ-cell tumours 1-gen-2005 De Giorgi, U; Rosti, G; Slavin, S; Yaniv, I; Harousseau, Jl; Ladenstein, R; Demirer, T; Dini, G
First-Line PAzopanib in NOn–clear-cell Renal cArcinoMA: The Italian Retrospective Multicenter PANORAMA Study 1-gen-2017 Buti, S; Bersanelli, M; Maines, F; Facchini, G; Gelsomino, F; Zustovich, F; Santoni, M; Verri, E; De Giorgi, U; Masini, C; Morelli, F; Vitale, Mg; Sava, T; Prati, G; Librici, C; Fraccon, Ap; Fornarini, G; Maruzzo, M; Leonardi, F; Caffo, O
The Khorana Score in Predicting Venous Thromboembolism for Patients With Metastatic Urothelial Carcinoma and Variant Histology Treated With Chemotherapy 1-gen-2017 Ramos, Jd; Casey, Mf; Bamias, A; De Giorgi, U; Bellmunt, J; Harshman, Lc; Ladoire, S; Wong, Yn; Alva, As; Rosenberg, Je; Galsky, Md; Yu, Ey
PSMA expression: A potential ally for the pathologist in prostate cancer diagnosis 1-gen-2018 Bravaccini, S.; Puccetti, M.; Bocchini, M.; Ravaioli, S.; Celli, M.; Scarpi, E.; De Giorgi, U.; Tumedei, M. M.; Raulli, G.; Cardinale, L.; Paganelli, G.
Innovative therapy for patients with brain metastases: oral treatments 1-gen-2004 Kopf, B; De Giorgi, U; Zago, S; Carminati, O; Rosti, G; Marangolo, M
GSTP1 Methylation and Protein Expression in Prostate Cancer: Diagnostic Implications 1-gen-2016 Martignano, F; Gurioli, G; Salvi, S; Calistri, D; Costantini, M; Gunelli, R; De Giorgi, U; Foca, F; Casadio, V
18F-Fluorocholine PET/CT for early response assessment in patients with metastatic castration-resistant prostate cancer treated with enzalutamide 1-gen-2015 De Giorgi, U; Caroli, P; Scarpi, E; Conteduca, V; Burgio, Sl; Menna, C; Moretti, A; Galassi, R; Rossi, L; Amadori, D; Paganelli, G; Matteucci, F
Plasma Androgen Receptor and Docetaxel for Metastatic Castration-resistant Prostate Cancer 1-gen-2019 Conteduca, V.; Jayaram, A.; Romero-Laorden, N.; Wetterskog, D.; Salvi, S.; Gurioli, G.; Scarpi, E.; Castro, E.; Marin-Aguilera, M.; Lolli, C.; Schepisi, G.; Maugeri, A.; Wingate, A.; Farolfi, A.; Casadio, V.; Medina, A.; Puente, J.; Vidal, M. J. M.; Morales-Barrera, R.; Villa-Guzman, J. C.; Hernando, S.; Rodriguez-Vida, A.; Gonzalez-del-Alba, A.; Mellado, B.; Gonzalez-Billalabeitia, E.; Olmos, D.; Attard, G.; De Giorgi, U.
Role and relevance of quality indicators in the selection of first-line treatment of patients with metastatic renal cell carcinoma: A position paper of the MeetURO Group 1-gen-2019 Procopio, G.; Pignata, S.; Altavilla, A.; Attademo, L.; De Lisi, D.; Verzoni, E.; De Giorgi, U.; Santini, D.
Plasma AR status and cabazitaxel in heavily treated metastatic castration-resistant prostate cancer 1-gen-2019 Conteduca, V; Castro, E; Wetterskog, D; Scarpi, E; Jayaram, A; Romero-Laorden, N; Olmos, D; Gurioli, G; Lolli, C; Sáez, Mi; Puente, J; Schepisi, G; Salvi, S; Wingate, A; Medina, A; Querol-Niñerola, R; Marin-Aguilera, M; Arranz, Ja; Fornarini, G; Basso, U; Mellado, B; Gonzalez-Billalabeitia, E; Attard, G; De Giorgi, U
68 Ga-PSMA PET/CT in patients with recurrent prostate cancer after radical treatment: prospective results in 314 patients 1-gen-2018 Caroli, Paola; Sandler, Israel; Matteucci, Federica; de Giorgi, Ugo; Uccelli, Licia; Celli, Monica; Foca, Flavia; Barone, Domenico; Romeo, Antonino; Sarnelli, Anna; Paganelli, Giovanni
Prolonged exposure to (R)-bicalutamide generates a LNCaP subclone with alteration of mitochondrial genome 1-gen-2014 Sara, Pignatta; Chiara, Arienti; Wainer, Zoli; Marzia Di, Donato; Gabriella, Castoria; Gabucci, Elisa; Casadio, Valentina; Falconi, Mirella; DE GIORGI, UGO FEDERICO FRANCESCO; Rosella, Silvestrini; Tesei, Anna
Adjuvant high-dose chemotherapy with autologous hematopoietic stem cell transplantation for high-risk breast cancer: results from the italian National Registry 1-gen-2014 Pedrazzoli, Paolo; Martinelli, Giovanni; Gianni, Alessandro Massimo; Da Prada, Gian Antonio; Ballestrero, Alberto; Rosti, Giovanni; Frassineti, Giovanni Luca; Aieta, Michele; Secondino, Simona; Cinieri, Saverio; Fedele, Roberta; Bengala, Carmelo; Bregni, Marco; Grasso, Donatella; De Giorgi, Ugo; Lanza, Francesco; Castagna, Luca; Bruno, Barbara; Martino, Massimo; Gruppo Italiano per il Trapianto di Midollo Osseo, Cellule staminali emopoietiche e terapia cellulare
Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study 1-gen-2017 Conteduca, V; Wetterskog, D; Sharabiani, Mta; Grande, E; Fernandez-Perez, Mp; Jayaram, A; Salvi, S; Castellano, D; Romanel, A; Lolli, C; Casadio, V; Gurioli, G; Amadori, D; Font, A; Vazquez-Estevez, S; González Del Alba, A; Mellado, B; Fernandez-Calvo, O; Méndez-Vidal, Mj; Climent, Ma; Duran, I; Gallardo, E; Rodriguez, A; Santander, C; Sáez, Mi; Puente, J; Gasi Tandefelt, D; Wingate, A; Dearnaley, D; Premiere, Collaborators; Spanish Oncology Genitourinary, Group; Demichelis, F; De Giorgi, U; ‡ Gonzalez-Billalabeitia, E; ‡ Attard G ‡., ‡These three authors jointly supervised this work as co-senior authors
Amifostine (Ethyol) as modulator of hepatic and biliary toxicity from intrarterial hepatic chemoembolization: results of a phase I study 1-gen-2001 Fiorentini, G; Giovanis, P; Leoni, M; De Giorgi, U; Cariello, A; Dazzi, C; Caldeo, A
Is high-dose chemotherapy after primary chemotherapy a therapeutic option for patients with primary mediastinal nonseminomatous germ cell tumor? 1-gen-2006 Banna, Gl; De Giorgi, U; Ferrari, B; Castagna, L; Alloisio, M; Marangolo, M; Rosti, G; Santoro, A.
Real-life clinical practice results with vinflunine in patients with relapsed platinum-treated metastatic urothelial carcinoma: an Italian multicenter study 1-gen-2017 Passalacqua, R; Lazzarelli, S; Donini, M; Montironi, R; Tambaro, R; De Giorgi, U; Pignata, S; Palumbo, R; Ceresoli, Gl; Del Conte, G; Tonini, G; Morelli, F; Nolè, F; Panni, S; Rondini, E; Guida, A; Zucali, Pa; Doni, L; Iezzi, E; Caminiti, C
CYP17A1 polymorphisms and clinical outcome of castration-resistant prostate cancer patients treated with abiraterone 1-gen-2016 Salvi, S; Casadio, V; Burgio, Sl; Conteduca, V; Rossi, L; Menna, C; Carretta, E; Costantini, M; Zoli, W; De Giorgi, U
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 601 a 620 di 38.604
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile

Scopri
Tipologia
  • 03 Articolo su Rivista38604
Autore
  • SPAGNOLO, Stefania Antonia1590
  • GORINI, Edoardo1578
  • VENTURA, Andrea1508
  • PRIMAVERA, Margherita1313
  • CHIODINI, GABRIELE1056
  • GRAVILI, FRANCESCO GIUSEPPE648
  • GIGLI, Giuseppe468
  • CINGOLANI, Roberto438
  • DE GIORGI, UGO FEDERICO FRANCESCO437
  • LONGO, LUIGI388
Data di pubblicazione
  • In corso di stampa43
  • 2020 - 202710432
  • 2010 - 201913552
  • 2000 - 20098692
  • 1990 - 19993962
  • 1980 - 19891442
  • 1970 - 1979447
  • 1961 - 196934
Editore
  • Elsevier BV:PO Box 211, 1000 AE A...454
  • American Institute of Physics:2 H...272
  • Giuffre Editore Spa:via Busto Ars...128
  • Elsevier Science Limited:Oxford F...99
  • Congedo Editore Luogo pubbl. Gal...72
  • IOP Publishing Limited:Dirac Hous...71
  • Springer Verlag Germany:Tiergarte...71
  • Kluwer Academic Publishers:Journa...54
  • IEEE / Institute of Electrical an...47
  • Societa Editrice il Mulino Spa:St...43
Rivista
  • JOURNAL OF HIGH ENERGY PHYSICS481
  • THE EUROPEAN PHYSICAL JOURNAL. C,...393
  • PHYSICS LETTERS. SECTION B392
  • PHYSICAL REVIEW LETTERS211
  • APPLIED PHYSICS LETTERS186
  • NUCLEAR INSTRUMENTS AND METHODS I...185
  • THE ASTROPHYSICAL JOURNAL180
  • PHYSICAL REVIEW D, PARTICLES, FIE...156
  • PHYSICAL REVIEW D148
  • ITINERARI DI RICERCA STORICA140
Keyword
  • ATLAS1158
  • LHC1151
  • High Energy Physics1130
  • Humans376
  • Mediterranean Sea185
  • Italy177
  • Female144
  • Animals143
  • Male127
  • Hadron-Hadron Scattering122
Lingua
  • eng25984
  • ita9002
  • fre415
  • spa191
  • ger146
  • por94
  • lat51
  • grc47
  • rus43
  • chi13
Accesso al fulltext
  • no fulltext32278
  • open4081
  • restricted1185
  • reserved1012
  • partially open32
  • mixed10
  • embargoed6